The Necessity of Bone Densitometry for Patients Taking Selective Serotonin Reuptake Inhibitors
Journal of Bone Metabolism
; : 95-98, 2013.
Article
em En
| WPRIM
| ID: wpr-159890
Biblioteca responsável:
WPRO
ABSTRACT
BACKGROUND: To analyze the necessity of bone densitometry for patients long-term taking selective serotonin reuptake inhibitors (SSRI) over a long period of time, which is one of the risk factors of osteoporosis. METHODS: We selected patients from 5 veterans hospitals who took SSRI for more than 2 months while taking bone densitometry on a regular basis. RESULTS: Of the 85 patients from a total of 5 veterans hospitals taking SSRI for more than two months, only 34 patients were under diagnosis and treatment measures of osteoporosis through checking each person's bone mineral density. CONCLUSIONS: It is necessary for patients taking SSRI to check bone density on a regular basis.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Osteoporose
/
Densidade Óssea
/
Prevalência
/
Fatores de Risco
/
Inibidores Seletivos de Recaptação de Serotonina
/
Densitometria
/
Diagnóstico
/
Hospitais de Veteranos
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Prevalence_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Journal of Bone Metabolism
Ano de publicação:
2013
Tipo de documento:
Article